Julie Dyrek, APRN
Psychiatric/Mental Health · Lake Charles, LANPI 1427668748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,800, 2.5 times the $1,112 reported in 2021. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $36.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$777
- Otsuka America Pharmaceutical, Inc.$722
- Teva Pharmaceuticals USA, Inc.$587
- E.r. Squibb & Sons, L.L.C.$336
- plus $3K from 14 others
What the payments were for
- Food & beverage$7,77599%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 67 | $1,517 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 45 | $1,137 |
| AbbVie | 30 | $777 |
| Otsuka America Pharmaceutical, Inc. | 20 | $722 |
| Teva Pharmaceuticals USA, Inc. | 9 | $587 |
| E.r. Squibb & Sons, L.L.C. | 8 | $336 |
| Gilead | 3 | $332 |
| Indivior Inc. | 13 | $297 |
| Johnson & Johnson | 2 | $258 |
| AstraZeneca(2 entities) | 2 | $244 |
| Vanda Pharmaceuticals Inc. | 2 | $243 |
| Novo Nordisk | 2 | $229 |
| Axsome Therapeutics, Inc. | 3 | $221 |
| Neurocrine Biosciences, Inc. | 5 | $218 |
| Bard Peripheral Vascular, Inc. | 2 | $198 |
| Pfizer | 1 | $116 |
| Bayer | 1 | $114 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $112 |
| Itamar Medical Inc | 1 | $104 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$2,389
- ARISTADA$460
- CAPLYTA$349
- INVEGA SUSTENNA$258
- VRAYLAR$246
- Fanapt$243
- COBENFY$238
- ABILIFY MAINTENA$236
- ABILIFY ASIMTUFII$236
- Epclusa$236
- REXULTI$235
- UZEDY$234
- NURTEC ODT$229
- UBRELVY$220
- SUBLOCADE$125
- Auvelity$125
- Ozempic$119
- AJOVY$117
- ARISTADA INITIO$115
- Kerendia$114
How this compares
$7,875 in reported general payments places this provider in the 90th percentile of 615 psychiatric/mental health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 19 | $287 |
| Gabapentin | 21 | $234 |
| Quetiapine Fumarate | 15 | $198 |
| Prazosin Hcl | 17 | $180 |
| Mirtazapine | 17 | $159 |
| Buspirone Hcl | 20 | $152 |
| Aripiprazole | 15 | $150 |
| Duloxetine Hcl | 19 | $137 |
| Trazodone Hcl | 19 | $133 |
| Olanzapine | 14 | $131 |
| Atorvastatin Calcium | 22 | $119 |
| Benztropine Mesylate | 12 | $117 |
| Amlodipine Besylate | 20 | $85 |
| Metformin Hcl | 12 | $38 |
| Escitalopram Oxalate | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Lake Charles
- Sattaria DilksLake Charles$57K
- Michelle DyerLake Charles$33K
- Erica HessiferLake Charles$13K
- Candyce BrownLake Charles$13K
- Bethanne CarsonLake Charles$12K
- Morgan UnserLake Charles$9K
- Eric RachalLake Charles$9K
- Lori KayLake Charles$9K
- Valarie ClarkLake Charles$8K
- Halie OryLake Charles$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.